—
C+
C+ The full Closelooknet — membership. Open the C+ overview

Repligen Corporation (RGEN) — chart, structure and Closelooknet read

Pick a ticker to load its detail page.

Signals for this name

Every Closelooknet reading that exists for RGEN, from the same nightly bakes the boards use. Research diary readings, not advice.

Weather around the name 3 macro readings: Money Temperature, Factor regime, Sovereign pressure

The weather around this name

Macro readings that apply by membership — the regime, the factor tape, the sector cell, the funding backdrop.

  • Money Temperature Composite 62/100 · S&P 500 fund at 67, bullish alignedEight instruments scored on position, momentum, volume, volatility and fragility — the regime every name trades inside. Temperature lab → 2026-09-25
  • Factor regime Momentum leading — risk appetite buildingMomentum against low volatility (SPMO / SPLV): above its 50-day trend, 99th percentile of the window, +8.4% over 20 sessions. Factor regime → 2026-09-25
  • Sovereign pressure Index 0.61 · up 0.29 over 21 sessionsG7 long-end yields, 10s30s and the slope — the funding weather for every balance sheet on this site. Sovereign pressure → 2026-09-25
How it trades on rate days beta 1.32 to TLT · on the worst bond days it moved with the market

How it trades on rate days

How RGEN has moved when long-dated Treasury yields rise — measured against TLT, the 20+ year Treasury fund.

  • Beta to long bonds, 1 year 1.32 — moves strongly with bonds for every 1% move in TLT (20+ year Treasuries), Repligen Corporation moved 1.32% on average · correlation 0.27 · higher than 94% of US names
  • Beta, last 3 months 1.56 more rate-sensitive lately than over the year
  • On the 10 worst bond days −0.90% on average against −0.74% for the S&P 500 the 10 sessions of the past year in which TLT fell most, i.e. long yields rose most
  • Latest of those days +3.32% TLT −1.29% that day 2026-09-24

Daily total returns from the adjusted price series; a TLT down day is a day long yields rose. Beta = the average move of the name for a 1% move in TLT. Past sensitivity, not a forecast. An investment diary, not a recommendation.

Who it is priced against Medical Instruments & Supplies · United States · 8 names with week and year-to-date

Peer group

Medical Instruments & Supplies · United States

This name carries no Closelooknet score, so its cohort ranks on trend state — distance to the 50- and 200-day averages — never on a score it does not have.

Compared against RGEN on the nightly bakes; the Peers tab ranks the cohort on the Closelooknet scores where it exists.

Company snapshot — Repligen Corporation

RGEN in five paragraphs: what it makes and sells, where it sits in the Closelooknet stack, who it is priced against, why we track it, what we watch. Research diary, not advice.

What it does
Repligen designs equipment and consumables used to manufacture biological drugs: filtration systems, chromatography columns, resins, and instruments that monitor a bioprocess as it runs. It sells to biopharmaceutical makers, diagnostics companies and contract manufacturers that produce drugs on their behalf. The company is based in Waltham, Massachusetts, and lists in the United States.
Where it sits in the stack
Repligen sits outside our index and outside the Closelooknet build-out stack; it belongs to the healthcare sector, in the medical instruments and supplies industry, where it supplies tools for drug manufacturing rather than chip or data-centre infrastructure.
Who it is priced against
The comparison the market draws is with other bioprocessing-equipment suppliers, among them Sartorius, whose filtration and chromatography lines overlap with Repligen's own.
Why Closelooknet tracks it
Repligen holds a seat in the Russell 1000 but carries no Rubin or Halo index membership; it does not yet carry a Closelooknet score, and the diary has recorded no quotes or edition mentions for it.
What the diary watches
Whether order volumes from biopharmaceutical manufacturers pick up again after the post-pandemic slowdown in capital spending on bioprocessing equipment.

Repligen Corporation (RGEN) trades on US exchanges.

Written from the company’s public profile and Closelooknet’s own readings, 2026-09-17. Descriptive, refreshed with the registry; corrections welcome via the imprint. closelook.net is an investment research diary — market structure, index membership and scores are our own readings, not investment advice. Related: index compare · sector dispersion · scanner.

FAQ · from the current data · as of 2026-09-26

Quick answers

What is Repligen Corporation (RGEN)?

Repligen Corporation trades as RGEN on the US exchange (United States) in the Closelooknet research universe, as of the registry build of 2026-09-26.

Is RGEN in a Closelooknet index?

Not currently — Repligen Corporation is tracked in the Closelooknet research universe but is not a constituent of a Closelooknet functional index as of 2026-09-26.

Where does RGEN trade against its moving averages?

Uptrend stack intact: Trades +14.9% vs the 50-day and +32.8% vs the 200-day average, 1.5% below the 52-week high and +87.8% off the 52-week low; a golden cross printed 32 sessions ago. Computed from daily closes. As of 2026-09-25 — a technical state from the nightly Closelooknet bake, not advice. The Technical tab carries the full row.

How does Repligen Corporation trade when bond yields rise?

Over the past year Repligen Corporation had a beta of 1.32 to TLT, the long-dated Treasury fund — it moves strongly with bonds, higher than 94% of US names. On the 10 sessions in which long bonds fell most it moved −0.90% on average, against −0.74% for the S&P 500. The "How it trades on rate days" block on this page carries the lines.

What does Repligen Corporation do?

Repligen designs equipment and consumables used to manufacture biological drugs: filtration systems, chromatography columns, resins, and instruments that monitor a bioprocess as it runs. It sells to biopharmaceutical makers, diagnostics companies and contract manufacturers that produce drugs on their behalf. The company is based in Waltham, Massachusetts, and lists in the United States. The comparison the market draws is with other bioprocessing-equipment suppliers, among them Sartorius, whose filtration and chromatography lines overlap with Repligen's own.

Where does Repligen Corporation sit in the AI build-out?

Repligen sits outside our index and outside the Closelooknet build-out stack; it belongs to the healthcare sector, in the medical instruments and supplies industry, where it supplies tools for drug manufacturing rather than chip or data-centre infrastructure. Repligen holds a seat in the Russell 1000 but carries no Rubin or Halo index membership; it does not yet carry a Closelooknet score, and the diary has recorded no quotes or edition mentions for it.

What does this page show?

A live price chart with SMA overlays and drawing tools for RGEN, performance metrics, index-membership context and the Closelooknet structure read — an investment research diary view, not investment advice.

Related in the Closelooknet universe

then Medical Instruments & Supplies. Scored names rank on their Closelooknet score; names without one rank on trend state — above or below their 50- and 200-day averages — never on a score they do not carry.